What Is a Buying Committee? Map It to MEDDIC and Score Your Coverage

Buying Committee Coverage Is a Forecast Signal, Not a CRM Field

A buying committee is the group of six to ten people who jointly decide whether your deal closes, and how many of them your rep has actually reached is the most honest risk signal in the deal. Gartner puts the typical complex B2B purchase at six to ten decision makers. Most reps have a real relationship with two or three. The distance between those numbers is where commit deals go to die.

We build revenue forecast models for B2B SaaS companies. When a safe-looking deal slips, the postmortem lands on the same cause almost every time. The deal was single-threaded, the empty seats on the committee were never named, and stage and amount looked fine right up until the quarter closed without it. Committee coverage fixes that. Map every stakeholder to a MEDDIC role, score the gaps, and you get a risk number you can read next to stage and amount.

Who Actually Sits on a B2B Buying Committee?

A buying committee is every person who can advance or veto the purchase, and each seat carries a different kind of authority. In a SaaS deal of any real size you are working some mix of these seats:

- Economic buyer, who controls the budget and gives the final yes. - Champion, who wants the deal and has the standing to push it internally. - Technical or security evaluator, who decides whether you clear the requirements. - End users, who live in the product and can sour the room if they are ignored. - Procurement and legal, who own the contract terms and the paper. - Executive sponsor, who ties the purchase to a company priority. - Blocker, who benefits from the status quo and works against you quietly.

Not every deal has all ten seats. The job is to know which seats exist and which ones you have covered.

How Do Buying Committee Roles Map to MEDDIC?

Each committee seat maps to a MEDDIC element, and the six letters tell you which seats you cannot leave empty. MEDDIC turns a loose list of contacts into a checklist of owned qualification. Here is the mapping I use. Three common seats do not own a letter and still decide the outcome: the blocker, the end users, and the executive sponsor. Track them alongside the six. A committee of ten collapses into six roles you must own and a handful of people who can still sink you.

How Do You Score Committee Coverage as a Deal-Risk Metric?

Score each of the six MEDDIC roles zero, one, or two, then add them for a coverage score out of twelve. The scale is deliberately blunt. Sum the six roles and read the total against the deal:

- 10 to 12: forecastable. You know who signs and why. - 7 to 9: at risk. You are single-threaded on at least one role that closes deals. - Below 7: this is not a commit, it is hope with a close date.

The number does the arguing for you in a pipeline review. A rep who calls a deal commit with a coverage score of 6 has to explain which four points are missing, and that conversation surfaces the real risk faster than any probability field ever will.

Why Does Coverage Predict Slippage Better Than Stage?

Because stage records where the deal sits in your process, while coverage records whether the people who actually close it are in the room. A deal can advance to a late stage on the strength of one enthusiastic contact and still be a coin flip. At ORM we see this constantly in forecast data. Pipeline coverage is not the forecast, and neither is stage: a deal concentrated in a single thread snaps the moment that contact goes quiet or leaves.

The earliest signal of deal slippage is not a red flag in the CRM. It is silence. No stage change, no returned calls. An unmapped committee seat is that same silence, priced in before it costs you. A zero on the economic buyer is not a gap to fill later. It is a live risk that stage will never show you.

How Do You Close a Coverage Gap Before It Costs You the Quarter?

Use your champion to earn access to the empty seats, and treat any seat you cannot reach as a confirmed risk rather than a neutral unknown. Ask the champion directly who signs and who quietly benefits if nothing changes. If a role stays at zero after two honest attempts to reach it, the deal is single-threaded on that role, and your forecast should carry the discount.

Coverage scoring buys you the one thing a late forecast cannot: time. Getting the call right in the last week of the quarter helps no one, because by then the quarter has already happened. A committee map built at stage two gives you weeks to multi-thread instead of a surprise on the final day. This is the input we build into the models at ORM, so a deal's risk shows up as a number on day one, not a lesson after the loss.